Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-2.07%
|
$136,220
$196.7 P/Share
|
|
Feb 27
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-2.49%
|
$93,492
$196.7 P/Share
|
|
Feb 24
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-1.83%
|
$35,532
$189.21 P/Share
|
|
Feb 24
2022
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,366
+24.71%
|
-
|
|
Feb 24
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.51%
|
$34,209
$189.21 P/Share
|
|
Feb 24
2022
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
2,124
+5.62%
|
-
|
|
Feb 24
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-0.97%
|
$35,532
$189.21 P/Share
|
|
Feb 24
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
2,126
+9.92%
|
-
|
|
Feb 24
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.79%
|
$50,841
$189.21 P/Share
|
|
Feb 24
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,443
+9.22%
|
-
|
|
Feb 24
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-0.59%
|
$221,130
$189.21 P/Share
|
|
Feb 24
2022
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
15,855
+7.45%
|
-
|
|
Feb 17
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.08%
|
$60,424
$182.42 P/Share
|
|
Feb 17
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
900
+2.84%
|
-
|
|
Feb 17
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.66%
|
$40,768
$182.42 P/Share
|
|
Feb 17
2022
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
450
+1.32%
|
-
|
|
Feb 17
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
175
-1.01%
|
$31,850
$182.42 P/Share
|
|
Feb 17
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
450
+2.53%
|
-
|
|
Feb 17
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-4.62%
|
$60,788
$182.42 P/Share
|
|
Feb 17
2022
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
900
+11.08%
|
-
|
|
Dec 14
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-2.56%
|
$112,140
$252.53 P/Share
|
|
Nov 18
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
17,355
-1.29%
|
$4,807,335
$277.22 P/Share
|
|
Nov 18
2021
|
Anthony Hunt |
SELL
Exercise of conversion of derivative security
|
Direct |
10,000
-4.77%
|
$320,000
$32.4 P/Share
|
|
Nov 10
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
4,783
-0.51%
|
$1,267,495
$265.15 P/Share
|
|
Nov 10
2021
|
Karen A Dawes |
SELL
Exercise of conversion of derivative security
|
Direct |
4,783
-4.74%
|
$124,358
$26.12 P/Share
|
|
Nov 04
2021
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
1,000
-7.5%
|
$288,000
$288.0 P/Share
|
|
Nov 02
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
2,400
-0.37%
|
$727,200
$303.19 P/Share
|
|
Nov 02
2021
|
Thomas F Ryan Jr Director |
BUY
Open market or private sale
|
Direct |
1,285
+8.79%
|
$388,070
$302.0 P/Share
|
|
Nov 02
2021
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,285
+8.08%
|
$164,480
$128.18 P/Share
|
|
Oct 29
2021
|
Nicolas Barthelemy |
SELL
Open market or private sale
|
Direct |
1,645
-29.57%
|
$473,760
$288.2 P/Share
|
|
Oct 29
2021
|
Nicolas Barthelemy |
BUY
Exercise of conversion of derivative security
|
Direct |
1,285
+28.7%
|
$164,480
$128.18 P/Share
|
|
Sep 14
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
274
-0.06%
|
$80,282
$293.45 P/Share
|
|
Sep 09
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
25,000
-3.01%
|
$7,375,000
$295.45 P/Share
|
|
Sep 09
2021
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.44%
|
$800,000
$32.4 P/Share
|
|
Sep 01
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
3,459
-0.6%
|
$978,897
$283.02 P/Share
|
|
Sep 01
2021
|
Karen A Dawes |
SELL
Exercise of conversion of derivative security
|
Direct |
3,459
-3.43%
|
$131,442
$38.76 P/Share
|
|
Sep 01
2021
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
3,377
-9.2%
|
$962,445
$285.33 P/Share
|
|
Aug 30
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
4,001
-18.74%
|
$1,128,282
$282.13 P/Share
|
|
Aug 18
2021
|
Karen A Dawes |
BUY
Open market or private sale
|
Direct |
40
+0.04%
|
$10,480
$262.31 P/Share
|
|
Aug 18
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
1,402
-0.37%
|
$363,118
$259.35 P/Share
|
|
Aug 17
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
17,514
-2.73%
|
$4,431,042
$253.67 P/Share
|
|
Aug 17
2021
|
Anthony Hunt |
SELL
Bona fide gift
|
Direct |
1,000
-0.52%
|
-
|
|
Aug 04
2021
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
780
-44.55%
|
$195,000
$250.5 P/Share
|
|
Jul 20
2021
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
4,585
-0.99%
|
$921,585
$201.69 P/Share
|
|
Jul 13
2021
|
Karen A Dawes |
BUY
Open market or private sale
|
Direct |
1,520
+1.28%
|
$307,040
$202.23 P/Share
|
|
Jul 13
2021
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
2,929
+2.4%
|
$120,089
$41.19 P/Share
|
|
Jun 10
2021
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
6,802
-24.16%
|
$1,285,578
$189.19 P/Share
|
|
Jun 10
2021
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,602
+6.1%
|
$259,344
$72.81 P/Share
|
|
May 19
2021
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
22,267
-1.37%
|
$3,807,657
$171.83 P/Share
|
|
May 14
2021
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
470
-1.45%
|
$80,840
$172.6 P/Share
|